Master of Science in Cancer Therapies

University of Strathclyde

UK,Scotland

 0 Shortlist

12 Months

Duration

CAD 27,500/year

Tuition Fee

CAD 0 FREE

Application Fee

Sep 2025

Apply Date

UK, Scotland

Type: University

Location Type: Urban

Founded: 1948

Total Students: 23,000 +

Int. Students: 3,700 +

Campus Detail

Main Campus Address

16 Richmond St, Glasgow G1 1XQ, United Kingdom

Master of Science in Cancer Therapies

Program Overview

The MSc in Cancer Therapies is unique in the UK. It's a multifaceted course and the only one which combines a focus on cancer biology, drug discovery, formulation and delivery with radiation biology. You'll also gain an understanding of the practical, ethical and economic implications of personalised cancer therapy. The degree is for graduates seeking experience in the range of topics essential to the understanding and development of cancer therapies.

You'll be taught in the Strathclyde Institute of Pharmacy & Biomedical Sciences, recognised as one of the leading departments of its kind in the UK. The Institute has major facilities for radiobiology and radiopharmaceutical research. It also hosts the Cancer Research UK Drug Formulation Unit – the only one of its kind in the UK. You'll therefore be taught by researchers working at the forefront of basic, translational, industrial and clinical cancer research in the biomedical and physical sciences arenas.

The course has been developed to produce world-class graduates with the skills to contribute to the global drive in advancing cancer treatment through research, teaching, industry and public sector employment.

Study with us

  • Unique in the UK
  • Combines a focus on cancer biology, drug discovery, formulation and delivery with radiation biology
  • Focus on anti-cancer treatment therapies, with a particular emphasis on a personalised medicine
  • Gain skills to contribute to the global drive to advance cancer treatment
  • Learn about cancer drug discovery development
  • For graduates seeking experience in the range of topics essential to the understanding and development of cancer therapies